Metabolic inhibitors rotenone and 2-deoxy glucose impair endothelium-dependent vasodilatation by distinct mechanisms involving EDRF production and smooth muscle sensitivity.
No takes yet. Share an insight, caveat, or question.
Metabolic inhibition of EDRF pathways may contribute to endothelial dysfunction; leaves open translation to human vessels and disease.
Weir et al. (1991) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: